abstract |
A liquid crystalline drug delivery system for ocular administration is provided. The drug delivery system comprises mucoadhesive, biocompatible, non-irritating and tissue permeable nanoparticles stably dispersed in an aqueous solution and may be formulated for sustained release. There is also provided a method of manufacturing the drug delivery system and a method of treating ocular disorders by administering the drug delivery system to a subject. |